T1	Participants 355 398	patients with hematuria of prostatic origin
T2	Participants 433 485	patients undergoing transurethral prostate resection
T3	Participants 585 659	70 patients scheduled to undergo elective transurethral prostate resection
T4	Participants 1535 1587	patients undergoing transurethral prostate resection
